verified SJR 0,635 · Q2 • database Scopus / SJR & Web of Science indexed

United States · SAGE Publications Inc.

workspace_premium Q2 — Medicine (miscellaneous) lock Subscription

Clinical and Applied Thrombosis/Hemostasis

Clinical and Applied Thrombosis/Hemostasis is a journal indexed in SJR in Medicine (miscellaneous) and Hematology with an H index of 65. It has an SJR impact factor of 0,635 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,635.

ISSN: 1076-0296

Publisher: SAGE Publications Inc.

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,635 Q2

H-index 65

Acceptance rate pie_chart

29% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,635

H-index

Docs (year)

137

Docs 3y

533

Total refs

5066

Cites 3y

1154

Citable 3y

499

Cites/Doc 2y

2.06

Ref/Doc

36.98

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Association of Meteorological Variables and Coronary Blood Flow

Venous Thromboembolism in Patients Undergoing Shoulder Arthroscopy

Do Postliver Transplant Patients Need Thromboprophylactic Anticoagulation?

Direct Oral Anticoagulants for the Management of Thromboembolic Disorders

Deep Venous Thrombosis of the Lower Limb: No Difference in Duration of Symptoms Between Proximal and Distal Disease

Correlation Between Maternal Plasma Thrombomodulin and Infant Birth Weight in Hypertensive Disorders of Pregnancy

Confounding Factors Should be Considered in Determining the Utility of Platelet Indices for Prediction of Recurrent Pregnancy Loss

Comparative Pharmacological Profiles of Various Bovine, Ovine, and Porcine Heparins

Clopidogrel Provides Significantly Greater Inhibition of Platelet Activity Than Aspirin When Combined With Atorvastatin After Coronary Artery Bypass Grafting: A Prospective Randomized Study

Clinical Features and Types of Von Willebrand Disease in Karachi

Clinical Characteristics and Outcome of Cardiovascular Implantable Electronic Device Infections in Turkey

Characterization of the Antithrombotic Fingerprint of the Branded and Copies of the Low-Molecular-Weight Enoxaparin Using Thrombin Generation Assay

SHOW MORE ARTICLES

Can Mean Platelet Volume be a New Risk Factor in Portal Venous Thrombosis?

"The End of Good Luck'' - Long-Term Survival Without Anticoagulation

Application of High-Throughput Sequencing in the Diagnosis of Inherited Thrombocytopenia

Antiphospholipid Antibodies and Procoagulant Profile in Tunisians With Inflammatory Bowel Diseases

An Open Label, Non-randomized, Prospective Clinical Trial Evaluating the Immunogenicity of Branded Enoxaparin Versus Biosimilars in Healthy Volunteers

Alteration in Mean Platelet Volume and Platicrit Values in Patients With Cancer That Developed Thrombosis

Adherence to Anticoagulant Therapy in Pediatric Patients Hospitalized With Pulmonary Embolism or Deep Vein Thrombosis

Acquired Hematological Abnormalities in Aortic Stenosis

A Woman With Rectal Sinus and Left Transversal Sinus Thrombosis After Ovarian Stimulation: Case Report

A Study of Human Killer Cell Immunoglobulin-Like Receptor and Multidrug Resistance Gene Polymorphisms in Children With Immune Thrombocytopenia

A Machine Learning-Based Model to Predict Acute Traumatic Coagulopathy in Trauma Patients Upon Emergency Hospitalization

A Comparison of the Biological Activity of 2 Formulations of Enoxaparin in 12 Healthy Volunteers

FAQs

Clinical and Applied Thrombosis/Hemostasis has an SJR of 0,635 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Clinical and Applied Thrombosis/Hemostasis is 29%.

Clinical and Applied Thrombosis/Hemostasis

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Clinical and Applied Thrombosis/Hemostasis?

What is the APC / publication cost?

What is the acceptance rate?